Early test of new shot to starve breast cancer
NCT ID NCT07310420
Summary
This early-stage trial is testing how well a hormone-blocking injection works for premenopausal women with advanced breast cancer that is fueled by hormones. The main goal is to see if the injection consistently lowers key hormone levels to suppress ovarian function. Researchers will measure hormone levels and monitor side effects in about 88 participants over 24 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duly Health and Care
Lisle, Illinois, 60532, United States
-
Presence Infusion Care
Skokie, Illinois, 60077, United States
-
Profound Research LLC at Michigan Hematology and Oncology Consultants
Royal Oak, Michigan, 48073, United States
Conditions
Explore the condition pages connected to this study.